VP of Dipexium Pharmaceuticals, Inc. just declared 45,000 options

Michael J. Dillon, VP of Dipexium Pharmaceuticals, Inc., has now declared ownership of 45,000 options from the company. The strike price of the options received was $7.97, and these expire on May 01, 2027.

Some additional info was provided as follows:

The Reporting Person was awarded 45,000 employee stock options on May 1, 2017 under the Issuer's 2015 Omnibus Incentive Plan. One-third of the grant becomes exercisable on the first anniversary of the grant date, with the remainder becoming exercisable in quarterly installments over the next two years following the first anniversary of the grant date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback